Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay H Traverse

Showing results (31-40 of 99) with videos related to

Pageof 10
Sort By:
JACC. Cardiovascular Imaging|June 18, 2011
Quantification of myocardial segmental function in acute and chronic ischemic heart disease and implications for cardiovascular cell therapy trials: a review from the NHLBI-Cardiovascular Cell Therapy Research NetworkJohn W Petersen, John R Forder, James D Thomas, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 1, 2010
Patients with coronary artery disease not amenable to traditional revascularization: prevalence and 3-year mortalityBenjamin Williams, Madhav Menon, Daniel Satran, et al.
JACC. Basic to Translational Science|November 12, 2019
First-in-Man Study of a Cardiac Extracellular Matrix Hydrogel in Early and Late Myocardial Infarction PatientsJay H Traverse, Timothy D Henry, Nabil Dib, et al.
European Heart Journal. Acute Cardiovascular Care|October 25, 2017
New or presumed new left bundle branch block in patients with suspected ST-elevation myocardial infarctionVijaya K Pera, David M Larson, Scott W Sharkey, et al.
Frontiers in Cardiovascular Medicine|September 20, 2021
Peripheral Blood Biomarkers Associated With Improved Functional Outcome in Patients With Chronic Left Ventricular Dysfunction: A Biorepository Evaluation of the FOCUS-CCTRN TrialLourdes Chacon Alberty, Emerson C Perin, James T Willerson, et al.
JACC. Cardiovascular Imaging|May 19, 2012
Cell tracking and the development of cell-based therapies: a view from the Cardiovascular Cell Therapy Research NetworkMartin Rodriguez-Porcel, Marvin W Kronenberg, Timothy D Henry, et al.
Critical Pathways in Cardiology|July 26, 2014
Ranolazine refractory angina registry: 1-year resultsNoel M Bennett, Vijay Iyer, Theresa L Arndt, et al.
The American Journal of Cardiology|April 26, 2006
Comparison of safety and efficacy of sirolimus-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarctionMarc C Newell, Christopher R Henry, Christopher J G Sigakis, et al.
American Heart Journal|February 16, 2023
Microvascular obstruction identifies a subgroup of patients who benefit from stem cell therapy following ST-elevation myocardial infarctionSarah J Davidson, Jerome Roncalli, Daniel Surder, et al.
American Heart Journal|September 10, 2010
Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarctionJay H Traverse, David H McKenna, Karen Harvey, et al.
Pageof 10

Showing results (31-40 of 99) with videos related to

Sort By:
Pageof 10
JACC. Cardiovascular Imaging|June 18, 2011
Quantification of myocardial segmental function in acute and chronic ischemic heart disease and implications for cardiovascular cell therapy trials: a review from the NHLBI-Cardiovascular Cell Therapy Research NetworkJohn W Petersen, John R Forder, James D Thomas, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 1, 2010
Patients with coronary artery disease not amenable to traditional revascularization: prevalence and 3-year mortalityBenjamin Williams, Madhav Menon, Daniel Satran, et al.
JACC. Basic to Translational Science|November 12, 2019
First-in-Man Study of a Cardiac Extracellular Matrix Hydrogel in Early and Late Myocardial Infarction PatientsJay H Traverse, Timothy D Henry, Nabil Dib, et al.
European Heart Journal. Acute Cardiovascular Care|October 25, 2017
New or presumed new left bundle branch block in patients with suspected ST-elevation myocardial infarctionVijaya K Pera, David M Larson, Scott W Sharkey, et al.
Frontiers in Cardiovascular Medicine|September 20, 2021
Peripheral Blood Biomarkers Associated With Improved Functional Outcome in Patients With Chronic Left Ventricular Dysfunction: A Biorepository Evaluation of the FOCUS-CCTRN TrialLourdes Chacon Alberty, Emerson C Perin, James T Willerson, et al.
JACC. Cardiovascular Imaging|May 19, 2012
Cell tracking and the development of cell-based therapies: a view from the Cardiovascular Cell Therapy Research NetworkMartin Rodriguez-Porcel, Marvin W Kronenberg, Timothy D Henry, et al.
Critical Pathways in Cardiology|July 26, 2014
Ranolazine refractory angina registry: 1-year resultsNoel M Bennett, Vijay Iyer, Theresa L Arndt, et al.
The American Journal of Cardiology|April 26, 2006
Comparison of safety and efficacy of sirolimus-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarctionMarc C Newell, Christopher R Henry, Christopher J G Sigakis, et al.
American Heart Journal|February 16, 2023
Microvascular obstruction identifies a subgroup of patients who benefit from stem cell therapy following ST-elevation myocardial infarctionSarah J Davidson, Jerome Roncalli, Daniel Surder, et al.
American Heart Journal|September 10, 2010
Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarctionJay H Traverse, David H McKenna, Karen Harvey, et al.
Pageof 10